BioSpace News Archive

Pharm Country

Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming September 2023 Investor Conferences

Intercept Pharmaceuticals, Inc. announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in fireside chats and investor meetings at the following upcoming investor conferences.

September 5, 2023

·

1 min read

BioCapital

YS Biopharma to Participate in Participate in Citi’s 18th Annual Biopharma Conference

YS Biopharma Co., Ltd. today announced that it will participate in in Citi’s 18th Annual Biopharma Conference from Tuesday, September 5 to Thursday, September 7, 2023.

September 5, 2023

·

1 min read

BioCapital

MIRA Pharmaceuticals and MZ Group Partner to Strengthen Investor Relations and Shareholder Communication Efforts

MIRA Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company focused on the development and commercialization of a novel synthetic THC analog, announced its strategic partnership with MZ Group, a renowned international investor relations firm.

September 5, 2023

·

5 min read

Genetown

Sarepta Therapeutics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, Sept. 11, 2023 at 8:40 a.m. E.T.

September 5, 2023

·

1 min read

Pharm Country

Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference

Tris Pharma, Inc. (Tris), today announced new data from a human abuse potential (HAP) study of cebranopadol (TRN-228) which suggest the investigational compound has significantly lower abuse potential compared to both schedule II and schedule IV opioids.

September 5, 2023

·

5 min read

Business

Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19

Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19.

September 5, 2023

·

6 min read

Lone Star Bio

CNS Pharmaceuticals (NASDAQ: CNSP) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

CNS Pharmaceuticals, Inc. today announced that John Climaco, CEO of CNS Pharmaceuticals, will present at the H.C. Wainwright 25th Annual Global Investment Conference being held in New York, NY on Wednesday, September 13, 2023 at 10:30 AM ET.

September 5, 2023

·

1 min read

Biotech Bay

89bio to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

89bio, Inc. today announced that the Company’s Management will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference, being held in New York, NY on Monday, September 11, 2023 at 7:00 pm.

September 5, 2023

·

1 min read

Biotech Beach

Aadi Bioscience to Participate at Upcoming Investor Conferences - September 5, 2023

Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with mTOR pathway alterations, announced today participation at the following investor events.

September 5, 2023

·

1 min read

Biotech Beach

Cardiff Oncology to Present at Upcoming Investor Conferences - September 5, 2023

Cardiff Oncology, Inc. today announced that company management will present at the Baird Global Healthcare Conference on September 12, 2023.

September 5, 2023

·

2 min read